The role of transdermal carbon dioxide on changes in malondialdehyde levels as a marker of ischemia-reperfusion injury in patients with placenta accreta spectrum underwent temporary abdominal aortic cross-clamping as an adjunct procedure during cesarean hysterectomy

Hari Daswin Pagehgiri; Ito  Puruhito; Aditiawarman; Pudji  Lestari; Yan Efrata  Sembiring; Dhihintia  Jiwangga; Arief Rakhman Hakim; Rozi Aditya Aryananda

doi:10.15562/bmj.v11i2.3646

The role of transdermal carbon dioxide on changes in malondialdehyde levels as a marker of ischemia-reperfusion injury in patients with placenta accreta spectrum underwent temporary abdominal aortic cross-clamping as an adjunct procedure during cesarean hysterectomy

Hari Daswin Pagehgiri ,

Ito Puruhito ,

Aditiawarman ,

Pudji Lestari ,

Yan Efrata Sembiring ,

Dhihintia Jiwangga ,

Arief Rakhman Hakim ,

Rozi Aditya Aryananda ,

pdf |
DOI: https://doi.org/10.15562/bmj.v11i2.3646 |
Published: 2022-08-31

Abstract

Background: Temporary abdominal aortic cross-clamping is often applied as an adjunct procedure to control bleeding in patients with placenta accreta spectrum during cesarean hysterectomy. It is claimed to reduce the blood loss need for transfusion and improve visualization of the operating field. After the cross-clamp is removed, the tissue distal to the occlusion, which was initially in an ischemic state, gets a sudden blood flow causing ischemia-reperfusion injury due to the release of ROS. Transdermal administration of carbon dioxide is expected to reduce the release of ROS through the Bohr Effect to protect against ischemia-reperfusion injury, which can be seen from the level of malondialdehyde.

Method: This experimental study recruited all patients with placenta accreta spectrum who underwent temporary abdominal aortic cross-clamping during cesarean hysterectomy from January to June 2022. Subjects were divided into control groups and treatment groups. The treatment group was given transdermal CO₂ immediately after the aortic cross-clamp was removed. The plasma MDA levels were examined before and after aortic cross-clamping.

Results: The number of subjects in each group was 7 subjects. There was an increase in MDA levels from 19.779+0.870nmol/ml to 21.104+1.053nmol/ml after cross-clamp in all groups, with an average increase of 1.325+0.801nmol/ml (p=0.00). The treatment group that received transdermal CO₂ had a lower tendency to increase MDA levels, 1.063+0.803nmol/ml, compared to the control group at 1.586+0.766nmol/ml.

Conclusion: There was an increase in MDA levels as a predictor of ischemia-reperfusion injury in patients undergoing temporary abdominal aortic cross-clamping. The administration of transdermal CO₂ tends to suppress ischemia-reperfusion injury.

References

Society of Gynecologic Oncology; American College of Obstetricians and Gynecologists and the Society for Maternal–Fetal Medicine, Cahill AG, et al. Placenta Accreta Spectrum. Am J Obstet Gynecol. 2018;219(6):B2-B16. doi:10.1016/j.ajog.2018.09.042.
Jauniaux E, Bunce C, Grønbeck L, Langhoff-Roos J. Prevalence and main outcomes of placenta accreta spectrum: a systematic review and meta-analysis. Am J Obstet Gynecol. 2019;221(3):208-218. doi:10.1016/j.ajog.2019.01.233.
Aditiawarman AR, Akbar MA, Darmawan E, and Sulistyono A. Epidemiology and the Emerging of PASD in Indonesia. 2020. p284–287.
Aryananda RA. Resurgence of placenta accreta in Indonesia. Maj. Obstet. Ginekol. 2019;(26)98. DOI:10.20473/mog.V26I32018.98-99.
Chou MM, Chen MJ, Su HW, et al. Vascular control by infrarenal aortic cross-clamping in placenta accreta spectrum disorders: description of technique. BJOG. 2021;128(6):1030-1034. doi:10.1111/1471-0528.16605.
Zammert M, Gelman S. The pathophysiology of aortic cross-clamping. Best Pract Res Clin Anaesthesiol. 2016;30(3):257-269. doi:10.1016/j.bpa.2016.07.006.
Wu MY, Yiang GT, Liao WT, et al. Current Mechanistic Concepts in Ischemia and Reperfusion Injury. Cell Physiol Biochem. 2018;46(4):1650-1667. doi:10.1159/000489241.
Ismaeel A, Lavado R, Smith RS, et al. Effects of Limb Revascularization Procedures on Oxidative Stress. J Surg Res. 2018;232:503-509. doi:10.1016/j.jss.2018.07.024.
Gaweł S, Wardas M, Niedworok E, Wardas P. Dialdehyd malonowy (MDA) jako wskaźnik procesów peroksydacji lipidów w organizmie [Malondialdehyde (MDA) as a lipid peroxidation marker]. Wiad Lek. 2004;57(9-10):453-455.
Grotto D. et al. Importance of the lipid peroxidation biomarkers and methodological aspects for malondialdehyde quantification. Quim Nova. 2009;32. p169–174. DOI:10.1590/S0100-40422009000100032.
Satria, D., Sembiring, Y. E., Kurniasari, N. & Lestari, P. Combination Therapy of N-Acetylcysteine and Simvastatin Reduce Malondialdehyde (MDA) Levels in Animal Models with Ischemic/Reperfusion Injury (IRI). Annals of the Romanian Society for Cell Biology, 2021;25(6). p18712–18719.
Pergel A, Tümkaya L, Demiral G, et al. The protective effects of adalimumab on intestinal injury induced with infrarenal aortic occlusion. İnfrarenal aort oklüzyonu ile oluşan intestinal hasarında adalimumab'ın koruyucu etkisi. Ulus Travma Acil Cerrahi Derg. 2020;26(3):366-372. doi:10.14744/tjtes.2019.59607.
Fabry R, Monnet P, Schmidt J, et al. Clinical and microcirculatory effects of transcutaneous CO2 therapy in intermittent claudication. Randomized double-blind clinical trial with a parallel design. Vasa. 2009;38(3):213-224. doi:10.1024/0301-1526.38.3.213.
Finzgar M, Melik Z, Cankar K. Effect of transcutaneous application of gaseous carbon dioxide on cutaneous microcirculation. Clin Hemorheol Microcirc. 2015;60(4):423-435. doi:10.3233/CH-141898.
Sakai Y, Miwa M, Oe K, et al. A novel system for transcutaneous application of carbon dioxide causing an "artificial Bohr effect" in the human body. PLoS One. 2011;6(9):e24137. doi:10.1371/journal.pone.0024137.
Hall JE and Hall ME. Transport of Oxygen and Carbon Dioxide in Blood and Tissue Fluids. Guyt Hall Textb Med Physiol. 2016;(14). p524.
Bolevich S, Kogan AH, Zivkovic V, et al. Protective role of carbon dioxide (CO2) in generation of reactive oxygen species. Mol Cell Biochem. 2016;411(1-2):317-330. doi:10.1007/s11010-015-2594-9.
Chen L, Wang X, Wang H, Li Q, Shan N, Qi H. Clinical evaluation of prophylactic abdominal aortic balloon occlusion in patients with placenta accreta: a systematic review and meta-analysis. BMC Pregnancy Childbirth. 2019;19(1):30. Published 2019 Jan 15. doi:10.1186/s12884-019-2175-0.
Riley DP, Burgess RW. External abdominal aortic compression: a study of a resuscitation manoeuvre for postpartum haemorrhage. Anaesth Intensive Care. 1994;22(5):571-575. doi:10.1177/0310057X9402200512.
Chou MM, Ke YM, Wu HC, et al. Temporary cross-clamping of the infrarenal abdominal aorta during cesarean hysterectomy to control operative blood loss in placenta previa increta/percreta. Taiwan J Obstet Gynecol. 2010;49(1):72-76. doi:10.1016/S1028-4559(10)60013-7.
Yoshida A, Miura K, Hasegawa Y, et al. A case of placenta previa accreta successfully treated by open infrarenal aortic clamping. Acta Medica Nagasakiensia. 2013;58. p93-95.
Chouchani ET, Pell VR, James AM, et al. A Unifying Mechanism for Mitochondrial Superoxide Production during Ischemia-Reperfusion Injury. Cell Metab. 2016;23(2):254-263. doi:10.1016/j.cmet.2015.12.009.
Slegtenhorst BR, Dor FJ, Rodriguez H, Voskuil FJ, Tullius SG. Ischemia/reperfusion Injury and its Consequences on Immunity and Inflammation. Curr Transplant Rep. 2014;1(3):147-154. doi:10.1007/s40472-014-0017-6.
Rabl H, Khoschsorur G, Colombo T, Tatzber F, and Esterbauer H. Human plasma lipid peroxide levels show a strong transient increase after successful revascularization operations. Free Radic. Biol. Med. 1992;13. p281–288. https://doi.org/10.1016/0891-5849(92)90175-G.
Rahmi C dan Puruhito I. Pengaruh Pemberian Transdermal CO2 Terhadap Hasil Perawatan Luka Kaki Diabetik Tipe I & II. IR - Perpust. Univ. AIRLANGGA 3. 2018.
Damanik, G., Puruhito, I., Aryananda, R. A., Lestari, P. & Soebroto, H. Transdermal CO 2 Increases Perfusion Index in Patients with Placenta Accreta Following Temporary Abdominal Aortic Cross-Clamping. Ann. Rom. Soc. Cell. Biol. 2021;25. p19918–19923.
Khan S, Khan S, Khan MM, Alam R, and Khan A. Estimation of The Status of MDA Levels and SOD Activity in Pregnant Women. Biochem. Cell. Arch. 2019;19. p169–173.
Sharma P, Prabha SS, Kumar P, and Sharma R. Estimation of malondialdehyde and catalase in pregnant & non-prenant women. Santosh Univ J Heal Sci. 2020;6. p21–25. DOI:10.18231/j.sujhs.2020.006.